Insider Trading › GEHC › Insiders

GE HealthCare Technologies Inc.

GEHC·Nasdaq·United States United States·Insider activity
$64.77
-0.97 (-1.48%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
GEHC
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GEHCS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

In the last 180 days, GEHC insiders filed 8 purchases ($6.4M) and 0 sales ($0) on the open market, by 8 insiders. Newest filing May 26, 2026 (4 months ago).

Net Insider Buying by Quarter

Shares bought (+) or sold (−) on the open market by GEHC insiders · Form 4 · last two years
-200.0K-100.0K0100.0K200.0K2025 Q1: -2,0002025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 103.7K2026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

On Record

$6.4MPurchases · 180 days
$0Sales · 180 days
23Open-market transactions on record
8Insiders filing · 180 days

Purchases (code P) and sales (code S) of GEHC common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).

Insider Transactions

23 on record · newest trade first
AllPurchasesSalesOfficers & directors
InsiderTypeSharesPriceValueHeld afterTradedFiled
Lobo KevinDirector Purchase +10.0K $64.18 $642K14.4Kdirect May 22, 2026May 26, 2026 Form 4 ↗
Hochman Rodney FDirector Purchase +1,618 $62.03 $100K1,618indirect May 12, 2026May 13, 2026 Form 4 ↗
Yang Watkin Phoebe L.Director Purchase +1,000 $63.01 $63K13.7Kdirect May 8, 2026May 11, 2026 Form 4 ↗
Stromberg William JDirector Purchase +1,000 $61.69 $62K15.3Kdirect May 6, 2026May 7, 2026 Form 4 ↗
CULP H LAWRENCE JRDirector Purchase +80.8K $61.88 $5.0M151.2Kindirect May 6, 2026May 7, 2026 Form 4 ↗
SACCARO JAMESChief Financial Officer Purchase +3,310 $60.60 $201K87.5Kdirect May 1, 2026May 1, 2026 Form 4 ↗
Jimenez Frank RGC & Corporate Secretary Purchase +1,750 $60.45 $106K93.9Kdirect Apr 30, 2026Apr 30, 2026 Form 4 ↗
Arduini Peter JPresident and CEO · Director Purchase +4,169 $59.93 $250K259.4Kdirect Apr 30, 2026Apr 30, 2026 Form 4 ↗
Newcomb George A.Chief Accounting Officer Sale −2,000 $92.54 $185K7,462direct Feb 18, 2025Feb 19, 2025 Form 4 ↗
Rott RolandCEO, Imaging Sale −3,577 $86.48 $309K24.3Kdirect Nov 6, 2024Nov 6, 2024 Form 4 ↗
Rackliffe PhilipCEO, AVS Sale −900 $87.63 $79K12.7Kdirect Nov 5, 2024Nov 5, 2024 Form 4 ↗
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc. Sale −19.0K $83.22 $1.6M38.5Kdirect Aug 14, 2024Aug 15, 2024 Form 4 ↗
Westrick Thomas J.CEO, Patient Care Solutions Sale −2,750 $80.78 $222K17.5Kdirect Aug 7, 2024Aug 7, 2024 Form 4 ↗
Kass-Hout TahaChief Technology Officer Sale −3,300 $78.70 $260K67.3Kdirect May 28, 2024May 29, 2024 Form 4 ↗
Makela JanCEO, Imaging Sale −67.0K $81.54 $5.5M63.3Kdirect May 15, 2024May 15, 2024 Form 4 ↗
Makela JanCEO, Imaging Sale −20.2K $81.57 $1.6M63.3Kdirect May 13, 2024May 15, 2024 Form 4 ↗
Jimenez Frank RGC & Corporate Secretary Purchase +1,315 $76.52 $101K75.8Kdirect May 1, 2024May 2, 2024 Form 4 ↗
O'Neill Kevin MichaelCEO, PDx Sale −13.3K $77.46 $1.0M24.0Kdirect Jul 31, 2023Aug 2, 2023 Form 4 ↗
O'Neill Kevin MichaelCEO, PDx Sale −2,334 $76.55 $179K24.0Kdirect Jul 31, 2023Aug 2, 2023 Form 4 ↗
Rott RolandCEO, Ultrasound Sale −2,473 $77.37 $191K22.3Kdirect Jun 8, 2023Jun 12, 2023 Form 4 ↗
Makela JanCEO, Imaging Sale −5,684 $78.07 $444K63.8Kdirect Mar 14, 2023Mar 16, 2023 Form 4 ↗
Makela JanCEO, Imaging Sale −64.9K $77.66 $5.0M69.5Kdirect Mar 14, 2023Mar 16, 2023 Form 4 ↗
CULP H LAWRENCE JRDirector Purchase +748 $69.26 $52K1,272indirect Jan 23, 2023Mar 24, 2023 Form 4 ↗

Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →